These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10555811)

  • 1. Hepatitis C lookback programme: a single hospital experience.
    Pawson R; Rajan S; Hazlehurst G; Dusheiko G; Miller R; Hewitt P; Mehta A
    Transfus Med; 1999 Sep; 9(3):189-93. PubMed ID: 10555811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Canadian experience with targeted hepatitis C virus lookback.
    Goldman M; Patterson L; Long A
    Transfusion; 2006 May; 46(5):690-4. PubMed ID: 16686835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfusion transmission of HCV infection before anti-HCV testing of blood donations in England: results of the national HCV lookback program.
    Transfusion; 2002 Sep; 42(9):1146-53. PubMed ID: 12430671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C.
    O'Riordan JM; Conroy A; Nourse C; Yap PL; McDonald GS; Kaminski G; Leong K; Lawlor E; Davoren A; Strong K; Davidson F; Lloyd A; Power J
    Transfus Med; 1998 Dec; 8(4):303-8. PubMed ID: 9881424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
    Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
    Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C lookback in Canada.
    Goldman M; Long A
    Vox Sang; 2000; 78 Suppl 2():249-52. PubMed ID: 10938962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transfusion-related hepatitis C. The Danish "look back" survey].
    Christensen PB; Grønbaek KE; Krarup HB
    Ugeskr Laeger; 2000 May; 162(18):2554-7. PubMed ID: 10846954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of transfusion to HCV infection in England.
    Soldan K; Ramsay M; Robinson A; Harris H; Anderson N; Caffrey E; Chapman C; Dike A; Gabra G; Gorman A; Herborn A; Hewitt P; Hewson N; Jones DA; Llewelyn C; Love E; Muddu V; Martlew V; Townley A
    Epidemiol Infect; 2002 Dec; 129(3):587-91. PubMed ID: 12558342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of post-transfusion hepatitis C: disease severity in blood-component recipients and their implicated donors.
    Smith BC; Chapman CE; Burt AD; Toms GL; Bassendine MF
    QJM; 1997 Sep; 90(9):587-92. PubMed ID: 9349451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a hepatitis C general transfusion lookback program for patients who received blood products before July 1992.
    Williams JL; Cagle HH; Christensen CJ; Fox-Leyva LK; McMahon BJ
    Transfusion; 2005 Jun; 45(6):1020-6. PubMed ID: 15935002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion-acquired hepatitis C: the Danish lookback experience. The Danish HCV [hepatitis C virus] Lookback Group.
    Christensen PB; Groenbaek K; Krarup HB
    Transfusion; 1999 Feb; 39(2):188-93. PubMed ID: 10037130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Discovery of a chronic HVC infection without seroconversion in a blood donor in France during 28 months].
    Durand F; Danic B; Tardivel R; Semana G; Gouezec H; Martinot M; Marcellin P; Beauplet A
    Transfus Clin Biol; 2000 Jun; 7(3):242-50. PubMed ID: 10919211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission of hepatitis C virus by transfusion in Orebro County, Sweden, 1990-1992.
    Norda R; Duberg AS; Sönnerborg A; Olcén P
    Scand J Infect Dis; 1995; 27(5):449-52. PubMed ID: 8588133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C in blood transfusion recipients identified at the Oxford Blood Centre in the national HCV look-back programme.
    Dike AE; Christie JM; Kurtz JB; Teo CG
    Transfus Med; 1998 Jun; 8(2):87-95. PubMed ID: 9675784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus transmission, 1988-1991, via blood components from donors subsequently found to be anti-HCV-positive.
    Foberg U; Ekermo B; Widell A; Mathiesen U; Fryden A
    Scand J Infect Dis; 1996; 28(1):21-6. PubMed ID: 9122627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus (HCV) RNA among anti-HCV-positive blood donors and their recipients.
    Skaug K; Li H; Jonassen TO; Larsen J; Figenschau KJ
    Vox Sang; 1993; 64(4):215-9. PubMed ID: 7685969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probability of receiving testing in a national lookback program: the English HCV experience.
    Transfusion; 2002 Sep; 42(9):1140-5. PubMed ID: 12430670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor-to-donor and donor-to-patient transmission of hepatitis C virus.
    Kitchen AD; Wallis PA; Gorman AM
    Vox Sang; 1996; 70(2):112-3. PubMed ID: 8801758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
    Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
    N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.